I thought most deals were "collaborations" and as such surely if something bigger and better comes along that would be shared with the partner asap. None of the producgs are yet approved for human trials so surely if something better comes along they would change to that. I guess there would be costs involved in swapping from old to new fpp but it would make no sense to keep progressing the 2nd rate candidate? Maybe this will be a big problem if they keep tunkering and improving.
PYC Price at posting:
3.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)